Contracting flu and COVID-19 simultaneously increases the risk of death, new study shows
September 23, 2020Research and Development coronavirus vaccine, flu vaccine, vaccines
Public Health England has warned that catching seasonal flu and coronavirus at the same time could almost double the risk …
Pharmafile.com’s weekly COVID-19 news round-up
September 23, 2020Research and Development COVID-19, coronavirus
The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …
AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal
September 22, 2020Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma
AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …
Clinical trials for Russia’s Sputnik-V vaccine in India could start in the coming weeks
September 22, 2020Manufacturing and Production Russia Vaccine, vaccines
Clinical trials testing Russia’s Sputnik-V coronavirus vaccine in India could begin in the next few weeks, according to Indian pharma …
CDC says its updated guidance stating coronavirus spreads through the air was posted in “error”
September 22, 2020Manufacturing and Production CDC, COVID-19
The US Centers for Disease Control and Prevention (CDC) has removed its guidance that said coronavirus was transmitted through the …
Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer
September 22, 2020Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma
MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus
September 22, 2020Manufacturing and Production OxyContin, Purdue, Purdue Pharma
Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …
New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020
September 21, 2020Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda
New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer
September 21, 2020Sales and Marketing AstraZeneca
AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …
Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency
September 21, 2020Sales and Marketing thyroid, thyroid drugs
Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …
Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020
September 21, 2020Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma
New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights
September 21, 2020Sales and Marketing COVID-19, air travel, coronavirus
The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying. …
Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma
September 18, 2020Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma
Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …
Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patients
September 18, 2020Medical Communications COVID-19, Roche
Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …
One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister
September 18, 2020Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine
Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing
September 18, 2020Medical Communications new york state, opioid crisis
New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …
Top Ten most popular articles on Pharmafile.com this week
September 18, 2020Medical Communications
The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …
Novartis’ Tafinlar/Mekinist combo improves five-year relapse-free survival in new Phase 3 data
September 17, 2020Research and Development Novartis, Tafinlar, mekinist, melanoma
Novartis has unveiled promising new Phase 3 data for its combination of Tafinlar (dabrafenib) with Mekinist (trametinib) in the treatment …
Opdivo scores NICE recommendation in two non-small cell lung cancer indications
September 17, 2020Sales and Marketing NICE, lung cancer, opdivo
NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …
Oxford University says participant illness that halted its COVID-19 trial may not be linked to the vaccine
September 17, 2020Research and Development coronavirus vaccines, vaccines
The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
